Nomograms for predicting survival in patients with metastatic gastric adenocarcinoma who undergo palliative gastrectomy

被引:0
作者
Tai Ma
Zhi-jun Wu
Hui Xu
Chang-hao Wu
Jing Xu
Wan-ren Peng
Lu-lu Fan
Guo-ping Sun
机构
[1] The First Affiliated Hospital of Anhui Medical University,Department of Oncology
[2] Anhui Institute for Cancer Prevention and Control,Faculty of Health and Medical Sciences
[3] University of Surrey,undefined
来源
BMC Cancer | / 19卷
关键词
Gastric adenocarcinoma; Palliative gastrectomy; Nomogram; Prognosis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 122 条
  • [1] Van Cutsem E(2016)Gastric cancer Lancet. 388 2654-2664
  • [2] Sagaert X(2016)Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial Lancet Oncol 17 309-318
  • [3] Topal B(2012)The value of palliative gastrectomy in gastric cancer with distant metastasis Ann Surg Oncol 19 1231-1239
  • [4] Haustermans K(2011)Outcome of palliative total gastrectomy for stage IV proximal gastric cancer Am J Surg 202 91-96
  • [5] Prenen H(2012)Non-curative gastrectomy for metastatic gastric cancer: rationale and long-term outcome in multicenter settings Eur J Surg Oncol 38 490-496
  • [6] Fujitani K(2016)The effect of the gastrectomy on survival in patients with metastatic gastric cancer: a study of ASMO Future Oncol 12 343-354
  • [7] Yang HK(2016)Palliative gastrectomy prolongs survival of metastatic gastric Cancer patients with Normal preoperative CEA or CA19-9 values: a retrospective cohort study Gastroenterol Res Pract 2016 6846027-106586
  • [8] Mizusawa J(2017)Palliative gastrectomy is beneficial in selected cases of metastatic gastric cancer BMC Palliat Care 16 19-7259
  • [9] Kim YW(2013)Clinical significance of palliative gastrectomy on the survival of patients with incurable advanced gastric cancer: a systematic review and meta-analysis BMC Cancer 13 577-970
  • [10] Terashima M(2017)Survival benefits of gastrectomy in gastric cancer patients with stage IV: a population-based study Oncotarget 8 106577-82